Disclosing accelerated approval on direct-to-consumer prescription drug websites.

Helen W SullivanAmie C O'DonoghueKathleen T DavidNisha J Patel

Published in: Pharmacoepidemiology and drug safety (2018)

Direct-to-consumer websites for brand-name accelerated approval prescription drugs do not consistently communicate the accelerated approval information for the product to consumers in a prominent, comprehensive, or readable manner.

Keyphrases

health information
drug administration
drug induced
emergency department
adverse drug